Inquiry Basket
Loading ......
Filter By Product Search for
bbs7
BBS7 Full Name
Bardet-Biedl syndrome 7
BBS7 Introduction
BBS7 (Bardet-Biedl syndrome 7) encodes a core component of the BBSome, an eight-subunit protein complex that regulates selective protein trafficking into and out of primary cilia. For researchers studying ciliopathies, BBS7 is particularly important because disruption of BBSome assembly can produce broad defects in ciliary signaling rather than a single isolated cellular phenotype. Current mechanistic models indicate that BBS7 is first stabilized by the CCT chaperonin system together with BBS6, BBS10, and BBS12, after which it participates in formation of the BBS2-BBS7-BBS9 core. Subsequent recruitment of BBS1, BBS4, BBS8, and other components completes the functional BBSome. This assembly pathway places BBS7 at an important structural position: correct folding, stability, and incorporation of BBS7 are prerequisites for efficient BBSome formation and ciliary protein trafficking.
Functionally, BBS7 contributes to the ability of the BBSome to recognize and regulate the movement of specific membrane proteins, including ciliary G protein-coupled receptors (GPCRs). Rather than acting as a conventional enzyme or signaling receptor, BBS7 functions primarily as part of the molecular machinery that organizes cargo trafficking at the primary cilium. Studies of the CEP19-RABL2-IFT-B pathway have further shown that BBSome-dependent export of ciliary GPCRs such as GPR161 and Smoothened is coordinated with intraflagellar transport machinery. Emerging ciliary proteomics research also links BBSome-dependent cargo removal to ubiquitin-based recognition mechanisms, highlighting how a BBS7-containing complex can participate in the controlled clearance of proteins from cilia. These findings make BBS7 a useful research target for investigating ciliary trafficking, GPCR signaling, intraflagellar transport, and the molecular basis of BBSome dysfunction.
Disease relevance is most clearly established in Bardet-Biedl syndrome (BBS), a genetically heterogeneous ciliopathy characterized by features that can include retinal degeneration, obesity, postaxial polydactyly, renal abnormalities, and reproductive or developmental abnormalities. Pathogenic BBS7 variants can impair BBSome assembly or function, ultimately disturbing ciliary protein homeostasis and signaling. The consequences are particularly evident in highly cilia-dependent tissues such as photoreceptors, where defective BBSome activity is associated with progressive retinal degeneration. Recent iPSC-based research has also connected cone photoreceptor degeneration in BBS models with persistent DNA damage responses and reported that pharmacological inhibition of Chk2 can mitigate this phenotype, suggesting that downstream stress pathways may provide additional therapeutic opportunities. For target discovery and disease-mechanism studies, BBS7 therefore represents more than a diagnostic gene: it is a central molecular entry point for understanding how defective ciliary trafficking translates into multisystem Bardet-Biedl syndrome phenotypes and for exploring strategies to restore ciliary function or protect vulnerable tissues.
Alternate Names for BBS7
BBS7; Bardet-Biedl syndrome 7; Bardet-Biedl syndrome 7 protein; BBS2L1; FLJ10715; BBS2-like 1; BBS2-like protein 1;
Loading ......
